15
Total deals
$103.9B
Total value
$9.4B
Avg deal
$63.0B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Capstan Therapeutics
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broa…
|
2025-06-30 | Acquisition | — | $2.1B | Deal → |
| 2 |
Nimble Therapeutics
Nimble Therapeutics is bringing the power of massively parallel chemical synthes…
|
2024-12-13 | Acquisition | Complete | $200.0M | Deal → |
| 3 |
Aliada Therapeutics
Aliada Therapeutics is a biotechnology company developing novel therapies to tre…
|
2024-10-28 | Acquisition | Complete | $1.4B | Deal → |
| 4 |
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicine…
|
2024-06-27 | Acquisition | Complete | $250.0M | Deal → |
| 5 |
Landos Biopharma
Landos Biopharma is a developer of an oral first-in-class therapeutics designed …
|
2024-03-25 | Acquisition | Complete | $212.0M | Deal → |
| 6 |
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat…
|
2023-12-06 | Acquisition | Complete | $8.7B | Deal → |
| 7 |
ImmunoGen
ImmunoGen engages in the research and development of antibody-based anticancer t…
|
2023-11-30 | Acquisition | Complete | — | Deal → |
| 8 |
DJS Antibodies
DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies aga…
|
2022-10-20 | Acquisition | Complete | $255.0M | Deal → |
| 9 |
Syndesi Therapeutics
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive …
|
2022-03-01 | Acquisition | Complete | $1.0B | Deal → |
| 10 |
Mitokinin
Mitokinin is operates in the healthcare industry focusing on biotechnology busin…
|
2021-03-10 | Acquisition | Complete | — | Deal → |
| 11 |
Mavupharma
Non-nucleotide, conditional modulators of the STING pathway to treat cancer and …
|
2019-07-15 | Acquisition | Complete | — | Deal → |
| 12 |
Allergan
Allergan is a global pharmaceutical company.
|
2019-06-25 | Acquisition | Complete | $63.0B | Deal → |
| 13 |
Stemcentrx
Stemcentrx provides pharmaceutical services.
|
2016-04-28 | Acquisition | Complete | $5.8B | Deal → |
| 14 |
Pharmacyclics
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on disc…
|
2015-03-04 | Acquisition | Complete | $21.0B | Deal → |
| 15 |
ImmuVen
ImmuVen develops drugs to treat infectious diseases, cancer, and autoimmune diso…
|
2014-01-01 | Acquisition | Complete | — | Deal → |